Free Trial

Revelation Biosciences (REVBW) Competitors

$0.0086 0.00 (-13.13%)
(As of 12/20/2024 05:31 PM ET)

REVBW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Revelation Biosciences vs.

180 Life Sciences (NASDAQ:ATNFW) and Revelation Biosciences (NASDAQ:REVBW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Revelation Biosciences'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Revelation Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Revelation Biosciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Revelation BiosciencesN/AN/AN/AN/AN/A

180 Life Sciences and Revelation Biosciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Revelation BiosciencesN/AN/A

Summary

180 Life Sciences and Revelation Biosciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Revelation Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for REVBW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

REVBW vs. The Competition

MetricRevelation BiosciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$165.68M$5.14B$9.08B
Dividend YieldN/A3.64%5.09%4.23%
P/E RatioN/A115.5190.0517.18
Price / SalesN/A18,531.021,116.25117.05
Price / CashN/A12.8743.1037.85
Price / BookN/A8.594.784.78
Net IncomeN/A-$20.67M$120.31M$225.60M
7 Day PerformanceN/A-1.05%-1.92%-1.23%
1 Month PerformanceN/A174.77%13.65%0.46%
1 Year PerformanceN/A134.18%28.34%15.24%

Revelation Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
REVBW
Revelation Biosciences
N/A$0.01
-13.1%
N/A-8.5%$0.00N/A0.0010
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+31.6%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+22.1%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
flat
N/A-89.6%$0.00$40,633.000.0040News Coverage
Gap Up
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+48.5%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.6676 of 5 stars
$12.05
+2.1%
$18.00
+49.4%
+6.9%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/A+408.0%$0.00N/A0.004
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+340.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/A-56.1%$0.00$193.06M0.00N/A

Related Companies and Tools


This page (NASDAQ:REVBW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners